Global response to the burden of cancer: the WHO approach
- PMID: 24857118
- DOI: 10.14694/EdBook_AM.2014.34.e311
Global response to the burden of cancer: the WHO approach
Abstract
As the burden of many cancer types of major public health relevance worldwide are in part determined by behavioral risks, much of the success of cancer control depends on the up take of prevention strategies at the population level. Over the last decade, the World Health Organization (WHO) has developed global prevention strategies of major relevance for cancer prevention and the prevention of other non-communicable diseases (NCDs), such as the 2003 WHO Framework Convention on Tobacco Control and others. The implementation of these core strategies gained momentum in 2011, when heads of states at the United Nation's (UN) High Level Meeting (HLM) on NCDs declared that NCDs are a global health threat that menaces social and economic development globally and requires urgent action. They asked for a paradigm change of the global health agenda by including NCD prevention and control into the group of priorities set by the Millennium Development Goals. WHO's translation of this call for action by the UN into practice has been consolidated into one clearly defined the WHO Global NCD Action Plan 2013-2020, including the pre-existing prevention strategies. Although cancer risk reduction will profit from the WHO Global NCD Action Plan, comprehensive cancer prevention and control will require other supplementary strategies not included in the plan because they are not shared with other NCDs. Causality of the over 200 cancer types is complex. A myriad of non-behavioral factors such as environmental and infectious risks, require specific attention when planning comprehensive cancer prevention. In reducing the cancer burden globally much will depend on how prevention strategies are implemented and how progress in cancer treatment can be translated into the reality of health systems in less affluent countries.
Similar articles
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
UN High-Level Meeting on Non-Communicable Diseases: addressing four questions.Lancet. 2011 Jul 30;378(9789):449-55. doi: 10.1016/S0140-6736(11)60879-9. Epub 2011 Jun 12. Lancet. 2011. PMID: 21665266
-
The process of prioritization of non-communicable diseases in the global health policy arena.Health Policy Plan. 2019 Jun 1;34(5):370-383. doi: 10.1093/heapol/czz043. Health Policy Plan. 2019. PMID: 31199439 Free PMC article.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Abnormal expression of YEATS4 associates with poor prognosis and promotes cell proliferation of hepatic carcinoma cell by regulation the TCEA1/DDX3 axis.Am J Cancer Res. 2018 Oct 1;8(10):2076-2087. eCollection 2018. Am J Cancer Res. 2018. PMID: 30416857 Free PMC article.
-
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives.Cell Prolif. 2015 Dec;48(6):705-17. doi: 10.1111/cpr.12224. Cell Prolif. 2015. PMID: 26597381 Free PMC article.
-
Pediatric Palliative Care Initiative in Cambodia.Front Public Health. 2017 Jul 28;5:185. doi: 10.3389/fpubh.2017.00185. eCollection 2017. Front Public Health. 2017. PMID: 28804708 Free PMC article.
-
Disparities in the incidence, mortality and disability-adjusted life years of 33 early-onset cancer groups globally, 2012-2021: a systematic analysis.Exp Hematol Oncol. 2025 Mar 17;14(1):38. doi: 10.1186/s40164-025-00634-7. Exp Hematol Oncol. 2025. PMID: 40098177 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous